A study of case management challenge for black grain eumycetoma during the ongoing war in Sudan
Key Clinical Message This case highlights the significant challenges in the diagnosis and management of eumycetoma, particularly in regions like Sudan, where socioeconomic factors and ongoing conflict severely impact patient care.
Emmanuel Edwar Siddig +2 more
doaj +3 more sources
Ibrexafungerp prolongs survival and reduces the eumycetoma grain size in Galleria mellonella infection models of two different causative agents of eumycetoma. [PDF]
Objectives Eumycetoma is a neglected tropical fungal disease of the subcutaneous tissue that is currently not treatable with medication only. Standard itraconazole therapy is combined with surgical excision of the lesion. Recently, ibrexafungerp, a novel
Ma J +5 more
europepmc +6 more sources
The development of a multiplex recombinase polymerase amplification reaction to detect the most common causative agents of eumycetoma. [PDF]
Mycetoma is a neglected tropical disease that affects the subcutaneous tissue. The disease can be caused by over 90 different pathogens, including both bacteria (actinomycetoma) and fungi (eumycetoma).
Konings M +8 more
europepmc +6 more sources
Management of Eumycetoma [PDF]
Background: Mycetoma is a chronic inflammatory disease of the skin that can extend to the fascia, tendons, muscles, and bones. Caused by a bacterium called actinomycetoma and a fungus called eumycetoma are responsible for mycetoma, both of which must be ...
Tjokorde Istri Nyndia Vaniari +5 more
doaj +2 more sources
Eumycetoma Medical Treatment: Past, Current Practice, Latest Advances and Perspectives
Mycetoma is a neglected tropical disease that is associated with poor communities and socioeconomically impaired individuals in the tropical and sub-tropical areas.
Emmanuel Edwar Siddig +6 more
doaj +3 more sources
Recurrent abdominal wall mass in a hepatitis B‐positive male: An unusual case of lumbar mycetoma
Key Clinical Message Atypical presentations of eumycetoma can pose a challenge in the diagnosis and treatment of the disease. Healthcare providers thorough in their differential diagnosis and investigations, even in the absence of classic symptoms, in ...
Alaa Tajeldeen Habeeb Abdallah +4 more
doaj +2 more sources
Madurella mycetomatis is highly susceptible to ravuconazole. [PDF]
The current treatment of eumycetoma utilizing ketoconazole is unsatisfactory because of high recurrence rates, which often leads to complications and unnecessary amputations, and its comparatively high cost in endemic areas.
Sarah Abdalla Ahmed +6 more
doaj +8 more sources
Using (1,3)-β-D-glucan concentrations in serum to monitor the response of azole therapy in patients with eumycetoma caused by Madurella mycetomatis [PDF]
Introduction: (1,3)-β-D-glucan is a panfungal biomarker secreted by many fungi, including Madurella mycetomatis, the main causative agent of eumycetoma.
Bakhiet, Sahar M. +7 more
core +3 more sources
The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection. [PDF]
Eumycetoma is a chronic progressive disabling and destructive inflammatory disease which is commonly caused by the fungus Madurella mycetomatis. It is characterized by the formation of multiple discharging sinuses.
Najwa A Mhmoud +3 more
doaj +8 more sources
Advanced eumycetoma with intracranial extension in three Sudanese patients: a case series and review of the literature. [PDF]
Eumycetoma is an endemic chronic granulomatous infection in tropical and subtropical regions, including Sudan. This case series presents three Sudanese patients with intracranial mycetoma (27-year-old female from Central Sudan, 20-year-old male from ...
Saadeldein MS +2 more
europepmc +2 more sources

